C07D 241/02
Not condensed with other rings
Official title: not condensed with other rings
C07D241/02 (Not condensed with other rings) appears on 3,667 US grants and 3,731 published applications in this corpus.
Search patents in C07D- Granted patents
- 3,667
- Published applications
- 3,731
- Assignees
- 1,489
- Inventors
- 10,901
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 32 | 0 |
| 1977 | 19 | 0 |
| 1978 | 28 | 0 |
| 1979 | 25 | 0 |
| 1980 | 31 | 0 |
| 1981 | 26 | 0 |
| 1982 | 17 | 0 |
| 1983 | 14 | 0 |
| 1984 | 35 | 0 |
| 1985 | 33 | 0 |
| 1986 | 30 | 0 |
| 1987 | 51 | 0 |
| 1988 | 43 | 0 |
| 1989 | 49 | 0 |
| 1990 | 52 | 0 |
| 1991 | 41 | 0 |
| 1992 | 40 | 0 |
| 1993 | 36 | 0 |
| 1994 | 39 | 0 |
| 1995 | 38 | 0 |
| 1996 | 37 | 0 |
| 1997 | 84 | 0 |
| 1998 | 61 | 0 |
| 1999 | 86 | 0 |
| 2000 | 61 | 0 |
| 2001 | 78 | 13 |
| 2002 | 79 | 91 |
| 2003 | 71 | 148 |
| 2004 | 60 | 155 |
| 2005 | 75 | 141 |
| 2006 | 69 | 109 |
| 2007 | 78 | 119 |
| 2008 | 71 | 118 |
| 2009 | 76 | 156 |
| 2010 | 97 | 184 |
| 2011 | 95 | 154 |
| 2012 | 134 | 144 |
| 2013 | 122 | 167 |
| 2014 | 159 | 181 |
| 2015 | 170 | 183 |
| 2016 | 129 | 162 |
| 2017 | 149 | 183 |
| 2018 | 132 | 137 |
| 2019 | 127 | 184 |
| 2020 | 143 | 191 |
| 2021 | 113 | 157 |
| 2022 | 120 | 145 |
| 2023 | 87 | 185 |
| 2024 | 77 | 123 |
| 2025 | 83 | 120 |
| 2026 | 65 | 81 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Salt containing piperazine polycyclic derivative, crystal form thereof, preparation method therefor, and use thereof6 Oct 2026US 12,753,166 B2Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- P38alpha mitogen-activated protein kinase inhibitors6 Oct 2026US 12,753,184 B2Gen1E Lifesciences Inc.
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents22 Sep 2026US 12,740,943 B2ModernaTX, Inc.
- Inhibitors and uses thereof22 Sep 2026US 12,740,991 B2Vividion Therapeutics, Inc.
- Bicyclic compounds8 Oct 2026US 2026/0308114 A1Vivace Therapeutics, Inc.
- Inhibitors of JUN N-Terminal Kinases (JNK1, JNK2, and/or JNK3) and Mitogen-Activated Protein Kinases (MAPK8, MAPK9, and/or MAPK10) and Methods of Using Same1 Oct 2026US 2026/0294922 A1
- Pyrazinecarboxamide analog compounds for use in treating cancer1 Oct 2026US 2026/0297064 A1Novapano LLC
- Modulators of sortilin activity24 Sep 2026US 2026/0285802 A1
- Bulky and small-steric-hindrance ligand and use thereof17 Sep 2026US 2026/0273518 A1Dg Hc Optical Co., Ltd
Most cited
By later US patents
- Photodecomposable bases and photoresist compositions470US 8,614,047 B2International Business Machines Corporation · 2013
- Lipids and compositions for intracellular delivery of biologically active compounds247US 8,691,750 B2Axolabs GmbH · 2014
- Arylsulfonyl hydroxamic acid derivatives as MMP and TNF inhibitors218US 5,861,510 APfizer Inc. · 1999
- Arylsulfonylamino hydroxamic acid derivatives213US 5,863,949 APfizer Inc. · 1999
- Nitrogen containing heteroaromatics as factor Xa inhibitors211US 6,020,357 ADuPont Pharmaceuticals Company · 2000